Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of stromal CXCR4 impairs development of lung metastases.
D'Alterio C, Barbieri A, Portella L, Palma G, Polimeno M, Riccio A, Ieranò C, Franco R, Scognamiglio G, Bryce J, Luciano A, Rea D, Arra C, Scala S. D'Alterio C, et al. Cancer Immunol Immunother. 2012 Oct;61(10):1713-20. doi: 10.1007/s00262-012-1223-7. Epub 2012 Mar 8. Cancer Immunol Immunother. 2012. PMID: 22399057 Free PMC article.
"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression".
Franco R, Botti G, Mascolo M, Loquercio G, Liguori G, Ilardi G, Losito S, La Mura A, Calemma R, Ierano C, Bryce J, D'Alterio C, Scala S. Franco R, et al. Front Biosci (Elite Ed). 2010 Jan 1;2(1):13-21. doi: 10.2741/e60. Front Biosci (Elite Ed). 2010. PMID: 20036848 Free article.
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.
D'Alterio C, Consales C, Polimeno M, Franco R, Cindolo L, Portella L, Cioffi M, Calemma R, Marra L, Claudio L, Perdonà S, Pignata S, Facchini G, Cartenì G, Longo N, Pucci L, Ottaiano A, Costantini S, Castello G, Scala S. D'Alterio C, et al. Curr Cancer Drug Targets. 2010 Nov;10(7):772-81. doi: 10.2174/156800910793605839. Curr Cancer Drug Targets. 2010. PMID: 20578990
Differential role of CD133 and CXCR4 in renal cell carcinoma.
D'Alterio C, Cindolo L, Portella L, Polimeno M, Consales C, Riccio A, Cioffi M, Franco R, Chiodini P, Cartenì G, Mirone V, Longo N, Marra L, Perdonà S, Claudio L, Mascolo M, Staibano S, Falsaperla M, Puglisi M, Martignoni G, Ficarra V, Castello G, Scala S. D'Alterio C, et al. Cell Cycle. 2010 Nov 15;9(22):4492-4500. doi: 10.4161/cc.9.22.13680. Cell Cycle. 2010. PMID: 21127401
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
D'Alterio C, Avallone A, Tatangelo F, Delrio P, Pecori B, Cella L, Pelella A, D'Armiento FP, Carlomagno C, Bianco F, Silvestro L, Pacelli R, Napolitano M, Iaffaioli RV, Scala S. D'Alterio C, et al. Int J Cancer. 2014 Jul 15;135(2):379-90. doi: 10.1002/ijc.28689. Epub 2014 Jan 10. Int J Cancer. 2014. PMID: 24375277
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.
Neve Polimeno M, Ierano C, D'Alterio C, Simona Losito N, Napolitano M, Portella L, Scognamiglio G, Tatangelo F, Maria Trotta A, Curley S, Costantini S, Liuzzi R, Izzo F, Scala S. Neve Polimeno M, et al. Cell Mol Immunol. 2015 Jul;12(4):474-82. doi: 10.1038/cmi.2014.102. Epub 2014 Nov 3. Cell Mol Immunol. 2015. PMID: 25363530 Free PMC article.
Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients.
Napolitano M, D'Alterio C, Cardone E, Trotta AM, Pecori B, Rega D, Pace U, Scala D, Scognamiglio G, Tatangelo F, Cacciapuoti C, Pacelli R, Delrio P, Scala S. Napolitano M, et al. Oncotarget. 2015 Apr 10;6(10):8261-70. doi: 10.18632/oncotarget.3014. Oncotarget. 2015. PMID: 25823653 Free PMC article.
64 results